Related Experiment Video
Updated: Dec 28, 2025

08:52
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
Published on: July 26, 2019
8.5K
Better influenza vaccines: an industry perspective
Juine-Ruey Chen1, Yo-Min Liu2,3, Yung-Chieh Tseng2
1RuenHuei Biopharmaceuticals, Inc., Taipei, 100, Taiwan.
Journal of Biomedical Science
|February 16, 2020
Summary
Next-generation influenza vaccines aim to overcome limitations of current shots. Innovations like glycoengineering may broaden protection against rapidly evolving flu viruses.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Current seasonal influenza vaccines offer limited protection against drifted strains.
- Annual reformulation struggles to keep pace with rapid influenza virus evolution.
- Vaccine effectiveness is often reduced due to strain mismatches.
Purpose of the Study:
- To review current influenza vaccine production methods.
- To summarize recent advances in influenza vaccine research.
- To highlight challenges and future directions in influenza vaccine development.
Main Methods:
- Review of existing literature on influenza vaccine production and development.
- Analysis of innovative techniques, including glycoengineering.
- Discussion of industry perspectives on novel vaccine candidates.
Main Results:
- Next-generation vaccines utilize innovative techniques to shorten production and broaden protection.
- Glycoengineering, by removing the glycan shield, shows potential to increase immunogenicity.
- Several novel influenza vaccine candidates are in development.
Conclusions:
- Novel influenza vaccines hold promise for improved protection against diverse and evolving strains.
- Glycoengineering represents a key strategy for enhancing vaccine immunogenicity.
- Overcoming production and regulatory challenges is crucial for future influenza vaccine development.
Related Concept Videos
Vaccinations
50.9K
Overview
50.9K
Microorganisms in Medicine and Therapeutics
861
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
861

